Lipid nanoparticles and transcranial focused ultrasound enhance the delivery of SOD1 antisense oligonucleotides to the murine brain for ALS therapy
Gayathri R. Ediriweera(ARC Centre of Excellence for Environmental Decisions), Kara L. Vine(University of Wollongong), Luke McAlary(University of Wollongong), Anthony R. White(QIMR Berghofer Medical Research Institute), Nicholas L. Fletcher(The University of Queensland), John Finnie(South Australia Pathology), Joshua D. Simpson(The University of Queensland), Gary Cowin(The University of Queensland), Mikayla Brown(University of Wollongong), Justin J. Yerbury(University of Wollongong), Joanna M. Wasielewska(German Center for Neurodegenerative Diseases), Jim Manavis(The University of Adelaide), Jeremy S. Lum(University of Wollongong), Liyu Chen(Shandong University), Kristofer J. Thurecht(The University of Queensland), Liam Robinson(University of Wollongong), Amal J. Sivaram(The University of Queensland)
Cited by 27
Related Papers
Metalloenzyme-like Activity of Alzheimer's Disease β-Amyloid
|Journal of Biological Chemistry|2002|575
Towards clinical translation of ligand-functionalized liposomes in targeted cancer therapy: Challenges and opportunities
|Journal of Controlled Release|2018|297
Degradation of the Alzheimer Disease Amyloid β-Peptide by Metal-dependent Up-regulation of Metalloprotease Activity
|Journal of Biological Chemistry|2006|283
Neuroprotective effects of apigenin against inflammation, neuronal excitability and apoptosis in an induced pluripotent stem cell model of Alzheimer’s disease
|Scientific Reports|2016|281
Cytotoxic and Anticancer Activities of Isatin and Its Derivatives: A Comprehensive Review from 2000-2008
|Anti-Cancer Agents in Medicinal Chemistry|2009|269